 |
인쇄하기
취소
|
Topamax Approved for Migraine Headache Prevention
The Korea Food and Drug Administration (KFDA) has recently approved Topamax (active ingredient: topiramate), an anti-seizure medication marketed by Janssen Korea, for prevention of migraine headaches in adults.
The approval now allows the domestic patients to receive preventive therapies for their migraines under the National Health Insurance (NHI) coverage as a reimbursable treatment. The...
The approval now allows the domestic patients to receive preventive therapies for their migraines under the National Health Insurance (NHI) coverage as a reimbursable treatment. The...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.